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Molecular docking and virtual screening experiments require large computational and data resources and high-level user interfaces 
in the form of science gateways. While science gateways supporting such experiments are relatively common, there is a clearly 
identified need to design and implement more complex environments for further analysis of docking results. This paper describes a 
generic framework and a related methodology that supports the efficient development of such environments. The framework is 
modular enabling the reuse of already existing components. The methodology, which proposes three techniques that the development 
team can use, is agile and encourages active participation of end-users. Based on the framework and methodology, two prototype 
implementations of science-gateway-based docking environments are presented and evaluated. The first system recommends a 
receptor-ligand pair for the next docking experiment, and the second filters docking results based on ligand properties. 




Molecular docking (often simply “docking”) is a computational simulation that models biochemical interactions 
to predict where and how two molecules would bind. A molecule is the smallest group of atoms that retain uniform 
biochemical properties. This paper focuses on two types of molecules: ligands - small molecules that can bind to other 
molecules, and receptors - large molecules that cause a biological change in a cell when a ligand is bound to them. 
Receptors are often proteins, polypeptides responsible for most functional and structural features in living organisms, 
made of a chain or a sequence of amino acids [1]. 
Large-scale docking simulations are used in areas such as drug discovery where they can decrease the amount of 
laboratory (wet-lab) experiments required to obtain a molecule that is a candidate drug. Large-scale docking of many 
ligands and one receptor is called virtual screening (VS). A typical VS experiment combines hundreds of thousands of 
docking simulations and is very computationally demanding, requiring the use of Distributed Computing 
Infrastructures (DCIs). Utilising and accessing such computational resources add an extra level of complexity to this 
task, making it increasingly difficult for biomedical scientists. Science gateways are widely used in this area to help 
bridge this gap. However, there is still a need for more complex environments that enable scientists to access a wide 
range of computing, data and network resources for the further analysis of docking results. These environments must 
enable scenarios where intelligent support can be provided for more efficient analysis of results of large-scale docking 
experiments. 
This paper investigates such scenarios and proposes a generic conceptual framework and a related methodology that 
uses regular input from scientists to support the development of complex science-gateway-based environments for 
the storage, analysis and reuse of molecular docking results. Further introduction to this topic and a detailed problem 
statement can also be found in our previous work [2].  
The proposed generic conceptual framework has been developed considering requirements collected from semi-
structured interviews with biomedical scientists and a literature review of 14 related projects, listed in Section 2. From 
this generic framework, specific architectures can be derived supporting various molecular-docking-related analytical 
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scenarios, as shown in Section 3. A software development methodology that supports creating software systems that use 
this framework is explained in Section 4. The methodology provides three techniques that can help the software 
development team determine which specific elements can be used in a scenario. In Section 5, the detailed design of 
two scenarios, based on the framework and methodology are presented followed by their implementation. This 
illustrates the utilisation of the three suggested techniques, and the benefits provided for the software developers, the 
primary beneficiaries. Usability tests in Section 6 broadly examine benefits of these implementations for the end-user, 
the biomedical scientist. Finally, Section 7 concludes the paper and outlines future work. 
2. Related Work 
The pioneering docking tool was first published in the 1980s. It was called DOCK [3] and considered both ligand 
and protein as rigid. One of its latest versions, DOCK6 [4], considers the flexibility of molecules too. Today there are 
over 50 available docking tools [5]. Proprietary docking tools such as GOLD [6] or FlexX [7] are an option, but 
AutoDock Error! Reference source not found. is reportedly the most popular docking tool based on number of 
citations [9]. An updated algorithm called AutoDock Vina Error! Reference source not found. is known to be faster 
and more accurate in certain cases [10]. In order to conduct a VS simulation, the user can write a custom script to run 
a docking tool multiple times. Alternatively, a VS tool with a graphical user interface (GUI) can also be used. 
Raccoon2 [12] is a desktop application for running VS simulations using AutoDock Vina. It provides a server 
connection manager for submitting jobs to a High-Performance Computing (HPC) cluster directly from the Raccoon2 
GUI. Raccoon2 supports only clusters with the Portable Batch System (PBS) or Sun Grid Engine (SGE) schedulers. 
While docking is used to estimate the binding affinity between a ligand and receptor, structural alignment is used 
to find similar receptors based on their structure (the three-dimensional position of atoms). Receptors can be compared 
by using their amino acid sequences in what is known as sequence alignment, but to understand its function or 
mechanisms of action, one needs to compare their three-dimensional structure. Based on available publications, it has 
been estimated that the number of new structural alignment tools doubles every 5 years [13]. The number of available 
structural alignment tools is over 100 [13-15]. The first major structural alignment tools started appearing in the 1990s 
with examples such as DALI [16] and CE [17]. A more recent tool that was top-ranked tool at the Critical Assessment 
of protein Structure Prediction (CASP) competitions CASP12 and CASP13, is RaptorX Structure Alignment server 
which uses the standalone tool DeepAlign [18].  
Given the vast number of docking or structural alignment tools to choose from, a modular component-based 
approach to developing software environments can be beneficial. In such an approach, a component is implemented 
using interfaces and a core unit. If the interfaces are compatible, the core unit may be seamlessly replaced. 
Furthermore, instead of designing and coding the environment from scratch, a component-based approach would 
focus around assembling and reusing components. Component-based software environments can be modelled using 
the standardised Component Diagram in Unified Modeling Language (UML) 2 [19]. This enables a high-level 
graphical model that documents the details of the environment, such as the components, their interfaces, and their 
interactions. Areas such as systems engineering can benefit from domain-specific modelling languages including 
sysML [20] or EAST-ADL [21]. Other methods that can be used to model component-based software environments 
rely on textual representation of formulas known as formal languages. Examples include the Vienna Definition 
Language (VDL) [22], Alloy [23] or Z notation [24]. A state-based formal language inspired by mathematical set 
theory, Z notation allows grouping of formal rules in “schemas” that can contain state variables while logical and 
discrete mathematics expressions describe systems using mathematical conventions.  
In conjunction with component-based approaches, environments that use molecular docking simulations are often 
developed as scientific workflows. Scientific workflow management systems enable users to run simulations on DCIs 
without any low-level programming, by merely specifying a workflow graph (where each node contains an 
executable, input, and output ports, and can be connected to other workflow nodes), and utilising built-in connectors 
to various DCIs. Scientific workflow engines that have been used for bioinformatics simulations such as VS include 
Kepler [25], Nextflow [26], Taverna [27], and WS-PGRADE/gUSE [28]. Workflows can be created graphically by 
drawing the nodes and edges, or textually by writing workflow description code. A workflow can be reused as a node 
in another workflow, i.e. it can be a sub-workflow. 
Existing environments for VS can be divided into VS pipelines which contain a set of scripts or tools to be used 
in a particular order, and workflow-based docking systems which automate the preparation, execution, and analysis 
of docking experiments using scientific workflows.  
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In a specific example [29], a pipeline has been used to explore the off-target activity of the drug Nelfinavir using 
reverse docking (many receptors, one ligand) as well as rescoring (reanalysis of top scored ligands using molecular 
mechanics methods). Other drug discovery pipelines composed of docking and rescoring, such as [30], have been run 
on HPC clusters. Clusters have also been used to run VS pipelines composed of a set of Perl scripts in [31] and [32]. 
In the former, top-ranking results of the docking are stored in the file system, while the latter includes a MySQL 
database for storing input and output files. Clusters are also used as part of the web solution in [33]. Cloud computing 
has also been used for docking simulations in [34], where a small desktop application has been developed to submit 
jobs on the cloud. Glaab [35] provides a review of current open-source programs that can be used in a VS pipeline, 
split into different elements, along with a rudimentary Docker container where selected tools are deployed.  
One example of a scientific workflow is WS-PGRADE and the gUSE services [36-38] which have been used to 
run docking experiments using various DCIs, such as clouds [39], grids [40] or HPC clusters [41]. In the latter 
example, interviews with one expert biochemist have been conducted to gather user requirements and implement a 
docking gateway. In all three examples, the results of the workflows are stored as part of the workflow management 
system, without additional metadata. On the other hand, in [42], a specific XML-based format has been created in 
order to store metadata about the execution, input, and output from three different molecular simulation domains, 
including docking. The workflows themselves can be stored in workflow repositories, such as myExperiment [43], or 
SHIWA Error! Reference source not found.. 
Additionally, there are many similar systems that implement bioinformatic simulations that are different from 
docking. In one example [45], a pipeline featuring multiple bioinformatic steps including prediction of a template 
ligand that would bind to a target receptor and searching for similar ligands is presented. This pipeline includes 
additional steps to combine and rank the results of the ligand similarity. Several other examples create portal-based 
systems for related analysis. For instance, a large system with 19 domains, including receptor-receptor docking (which 
is different from receptor-ligand docking) [46]. Smaller scale portals focus on one domain, such as [47], which focuses 
on molecular dynamics. Finally, many portals for bioinformatics use workflow-based technologies, such as the 
proteomics data analysis portal shown in [48]. 
Related system Type Stores simulation results Additional analysis 
Xie et al. [29] VS pipeline Y Y 
Zhang et al. [30] VS pipeline Y Y 
DOVIS 2.0 [31] VS pipeline Y Y 
D’Ursi et al. [32] VS pipeline Y Y 
HADDOCK 2.2 [33] VS pipeline Y  
Kiss et al. [34] VS pipeline Y  
Glaab [35] VS pipeline   
Farkas et al. [36] Workflow-based Y  
Kiss et al. [40] Workflow-based Y Y 
Jaghoori et al. [41] Workflow-based Y  
MoSGrid [42] Workflow-based Y Y 
Roy et al. [45] Docking-equivalent   
WeNMR [46] Docking-equivalent Y  
GridMACS [47] Docking-equivalent Y  
Kunszt et al [48] Docking-equivalent Y Y 
Table 1 – Related existing environments for VS divided according to type, whether they provide storage for 
simulation results, and whether they enable additional analysis of the results 
 
As shown in Table 1, some of the systems listed above do not store the simulation results and are mainly useful 
to provide the results directly to the user [35, 45]. Others store the results, but do not provide any additional analysis 
methods [33-34, 36, 46-47]. The remaining examples [29-32, 40, 42, 48] support additional analysis of the user’s own 
simulation results only, and do not provide the functionality to analyse results produced by other users.  
In this paper, we have gathered the specific types of components used in these 14 existing systems, as well as 
novel systems proposed through a series of interviews with five domain experts, in order to create a generic conceptual 
framework for systems that store docking results and provide additional analysis methods. The aim was to formalise 
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and speed up the development of such environments. To the best of our knowledge, when developing the systems 
shown in this section, software engineers used general software development methodologies which do not allow 
systematic analysis and reuse of existing building blocks. The methodology presented in this paper provides a formal 
manner of selecting components and determining whether they can be reused or whether a new component is suitable 
for the intended purpose. 
 
3. Generic Framework for the Analysis of Molecular Docking Results 
The aim of the presented research was to identify potential similarities in the work of biomedical scientists working 
with molecular docking experiments, and to investigate whether a generic framework for such application scenarios 
can be defined. The assumption was that based on this generic framework the development of specific science-gateway-
based environments supporting various molecular docking scenarios and the analysis of results can be formalized and 
speeded up.  
In order to identify typical user requirements, several interviews with five scientists from different backgrounds and 
with various degrees of experience with molecular docking simulations were conducted. This number of London-
based interviewees was useful in producing several conclusions. The interviews aimed at identifying requirements of 
the scientists when performing molecular docking experiments and specifying scenarios that are not supported by 
currently available science gateways for molecular docking. These scenarios typically represent software systems that 
make a decision based on the docking results, mimicking the steps that a scientist needs to take after obtaining the 
results. Some representative and identified scenarios are listed below: 
Scenario 1. Suggest a receptor-ligand pair that should be used in the next molecular docking, based on receptor 
similarity and previous results. 
Scenario 2. Filter docking results suitable for wet-lab experiments, based on ligand properties. 
Scenario 3. Find off-target drugs, based on deducing if the estimated binding is at an active site of the receptor. 
Scenario 4. Enable verification of the docking methodology and learning from previous docking for novice users. 
Scenario 5. Compare results from different molecular docking tools. 
 
Figure 1 – Basic diagram of the framework - arrows show possible dataflow connections between element 
types. A user uploads input to the MDE (1) and docking data may be sent to the MDRR (2) which sends this or 
previous docking data to ATs (3). An AT may communicate with other ATs (4) or look up data in an ADS (5). 
An AT may supply its calculation results to the MDRR for storage (6) and to the DM (7). The MDRR may 
receive data from an ADS (8) and the DM may use data from the MDRR (9) or an ADS (10). The decision can 
be passed back to the MDRR for storage (11) and finally to the MDE (12) which provides visualisation (13).   
Based on the conceptual similarities of these scenarios and an extended review of literature including the 14 papers 
referenced in Section 2, a generic framework has been designed. The design focuses on the similar elements in the 
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scenarios and includes the following element types (Figure 1): 
Molecular Docking Environment (MDE): All scenarios include an environment where the molecular docking 
simulation is executed. It could be as simple as running a single simulation from the command line on a local 
computer, to more complex such as executing a virtual screening experiment on a DCI. The MDE includes the software 
tool used for the docking itself, it may be connected to a DCI, or include a high-level user interface. 
Molecular Docking Results Repository (MDRR): After the execution of the molecular docking, the results and 
the input files need to be stored because previous docking results are useful for various scenarios. The repository shall 
also store information about the final decision made in the scenario. 
Additional Tool (AT): The results which have been stored in the MDRR are then processed by an AT. This is a 
generic element that describes a tool which takes data from the MDRR as input and conducts a calculation. ATs can 
refer back to other data stored in the MDRR, communicate with other ATs, or use data stored in an Additional Data 
Source. 
Additional Data Source (ADS): An ADS, such as an external database, shall contain data that is relevant for the 
final decision but is not docking result data or data referring to a docking simulation. 
Decision Maker (DM): All the information processed from the different ATs and the ADSs would be passed to 
a DM. This element groups and analyses the performed calculations in order to make a decision. 
The flow of data through the different element types is shown by the numbers in Figure 1.  
 
   
Figure 2 – Detailed diagram of the generic framework showing the location of needed interfaces. UML notation used 
as follows: rectangle with component symbol signifies “component”, small square - interaction “port”, stick with full 
white circle - “provided interface”, stick with black crescent - “required interface”, arrows show dataflow direction. 
A more detailed view of the framework consisting of a detailed diagram, a textual description of elements and 
interfaces, and a formal description using Z notation, has been developed. The framework aims to provide a formalised 
way to derive specific scenarios, independent from the software engineering details of the implementation.  The 
detailed diagram representing the framework in Figure 2 is a generic model, showing all generic element types and 
all possible types of interfaces between them. It is based on the UML Component Diagram with element types drawn 
as components and the types of interfaces as the typical provided and required interface connections. Additionally, it 
features arrows pointing towards the direction of the flow of data in a particular interface. 
The framework features 13 types of interfaces. Each of these interfaces have been identified and described with 
a textual description. Representative examples are provided here. For example: 
Interface 3: MDE → MDRR, provided by the MDE: allows the MDE to send docking results and additional data. 
Interface 4: MDRR → MDE, provided by the MDRR: allows the MDRR to send analysis results to the MDE. 
Following this, each element and each interface have been described formally using Z notation. A representative 
example of the formal description is presented here, describing the MDE and its interfaces (Figures 3 and 4). Please 
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note that the complete description of the generic framework, including both the textual description and the Z notation 
can be found at [49].  
 
Figure 3 – Abstract formal description of MDE using Z notation. The core computation maps the input pair LIGAND-
RECEPTOR or triple LIGAND-RECEPTOR-CONFIG into the docking RESULT in the functions 
dockingWithoutConfig() and dockingWithConfig() respectively. LIGAND, RECEPTOR, CONFIG, and RESULT 
have been defined as Z free types which describe the docking input/output files as sets of characters. Common 
mathematical symbols include: partial injective function ( ), input variable (suffix ?), and output variable (suffix !) 
The docking process expressed by the MDE needs a ligand, receptor, and optionally configuration (config) 
files as input, and provides a docking result file as output. The Z notation (Figure 3) shows that, depending on the 
presence of a config file, the functions dockingWithoutConfig() or dockingWithConfig() will generate the docking 
result. They describe that for every non-empty ligand×receptor pair, there exists a docking result. 
 
Figure 4 – Interface 1 described with Z notation using the input variables ligands?, receptors?, config?. Interfaces 2 
and 3 described using the output variables results! and date!, with the condition that the results cannot be empty. 
LIGANDS defined as a set of LIGAND, RECEPTORS as a set of RECEPTOR, RESULTS as a set of RESULT. 
DATE defined as a set of characters describing a calendar date. Z symbols include Ξ to indicate no change of state. 
Figure 4 models the MDE and interfaces 1, 2, and 3. This schema explains that the ligand, receptor, and config 
files are expected as input, while the docking results as well as information about the date are produced as output. The 
lower part of Figure 4 describes the interface that enables users to view results, as long as they exist.  
The generic framework presented in this section was described using the basic diagram, the detailed diagram, the 
textual description and the Z notation. It will be shown in Section 5 that this generic framework can be used to derive 
and design specific application scenarios in a systematic and reusable way.  
 
 
4. Methodology for Developing Environments for Analysis of Molecular Docking Results 
The methodology complements the framework described in the previous section by explaining how this 
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framework can be used during development. It clearly states the required roles (Life Scientist, Bioinformatician, 
Modeller, Software Developer, IT Infrastructure Administrator) and the specific deliverables (Diagram, Textual 
Description, Formal Description, Coding) for which these roles need to collaborate. The methodology is based on the 
seven principles identified by Cockburn [50]. A version of Cockburn’s role-deliverable-milestone diagram has been 
created to represent the methodology (Figure 5). In this type of diagram each role is drawn in a separate box along 
with a list of all deliverables that are related to that role. On top of the diagram all the milestones are listed. This 
provides a concise way for a person who has been given a role to view which milestone of which deliverable (s)he is 
required to work on. Reading the diagram vertically shows which roles need to work together to complete a milestone. 
Figure 5 illustrates that the Modeller, Life Scientist and Bioinformatician shall collaborate when creating the 
diagram and textual description of the scenario. Furthermore, the Modeller must collaborate with the Bioinformatician 
and the Software Developer when creating the formal description. Key components of this diagram, extensions to 
Cockburn's original diagram, are the dotted lines which show that the process is agile. This extension has been 
included to emphasise the need for a methodology that enables refinement and focuses on feedback from different 
roles. For instance, in the section where the Life Scientist works on the textual description (milestone M4 - M5), the 
dotted line shows that (s)he may revisit and alter the diagram if necessary. A key feature of this diagram is that it 
shows what role is needed for each deliverable and at which stage of the project. For instance, it shows that the Life 
Scientist is not required to produce the Formal Description. It also shows that during the coding, the Bioinformatician 
and Modeller may need to review the Formal Description. Finally, it shows that during the coding, the Modeller 
should work with the Software Developer to achieve milestone M11, while the Life Scientist and Bioinformatician 
should work with the Software Developer to achieve milestone M13. The asterisk (*) indicates that a similar but more 
detailed lower-level diagram of the coding has been developed (not presented in this paper but available in [49]). 
 
Figure 5 – Role-deliverable-milestone diagram of the proposed methodology. Roles on left, deliverables for each role 
in grey, milestones shown at top (M1: Diagram start; M2: Diagram ready for review; M3: Diagram ready; M4: Textual 
description start; M5: Textual description ready for review; M6: Textual description ready; M7: Formal description 
start; M8: Formal description ready for review; M9: Formal description ready; M10: Software development start; M11: 
Software developed; M12: Software installed/deployed; M13: Software tested). 
Besides the above diagram, the methodology also provides three techniques, based on the framework presented 
in Section 3. They can be used iteratively by the software development team during milestones M1-M9 because the 
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diagram, textual, and formal descriptions are used in the techniques. 
Technique 1. The basic diagram of the entire scenario can be used to determine whether the scenario fits the 
framework. 
Technique 2. The abstract (diagrammatic, textual, and formal) description of an element can be used to determine 
whether there is a similar element, already implemented using the framework, that can be reused. 
Technique 3. The abstract (diagrammatic, textual, and formal) description of a candidate tool can be used to 
determine whether this tool can be applied as an element in a scenario, by comparing it to the abstract 
description of a generic element type. This technique can be used if, using the framework, there is no already 
implemented element that can be reused, but there is an existing tool that has been implemented outside the 
framework (here called: candidate tool). 
The application of these techniques will be illustrated in Section 5 when demonstrating and evaluating the 
utilisation and effectiveness of the framework and the methodology. 
 
5. Evaluation of the framework and methodology using selected scenarios 
The evaluation of the framework and the methodology was divided into two phases. In the first phase, it was 
proven that the framework is generic enough to support at least the five identified scenarios and the 14 related solutions 
investigated in Section 2. In order to verify this, a basic diagram, similar to the ones presented in Figure 6 in case of 
Scenario 1 and Figure 10 in case of Scenario 2, has been derived from the basic diagram of the generic framework 
(Figure 1) for each of the 19 (5 scenarios + 14 related work) test cases. As these diagrams are based on the basic 
diagram of the generic framework and utilise some or all of its element types, it is reasonable to say that all five 
scenarios and 14 solutions identified from the literature fit the framework. It is also noted that, in this step, Technique 
1 from the methodology was applied to identify whether the scenarios fit the framework.   
In the second phase, in order to demonstrate how the framework and the methodology support implementing 
molecular docking science gateways, we developed an implementation of Scenarios 1 and 2 following the 
methodology and utilising its three techniques. In the remaining part of this section these implementations are detailed 
highlighting the utilisation of the framework and the methodology. Extracts of the diagrammatic descriptions are 
presented here, while the complete version of these descriptions together with the developed code is available at [49].   
5.1 Design and Implementation of Scenario 1 
In Scenario 1 the intended system is required to assist the scientist by searching for good previous docking results 
that have used a receptor similar to the currently used one. Based on this similarity the system shall suggest a new 
receptor-ligand pair that would be an interesting candidate for a future docking run. The docking results and receptor 
data stored in the MDRR could have been produced by the same scientist or other scientists in the past. Scientists may 
have used different MDEs to insert docking results and receptor data in the MDRR.  
As a first step, the basic diagram of the scenario (Figure 6) has been developed by replacing the building blocks 
of the generic framework (Figure 1) with functional elements supporting this particular scenario. At this step, 
Technique 1 of the methodology has been applied to assess which components of the generic framework are required 
and what their desired functionality is to implement the scenario. If such diagram can be derived, then the scenario 
fits the framework. Please note that at this stage we are not concerned about the actual implementation of the elements 
only about their desired functionality.  
Scenario 1 requires an MDE that supports docking or large-scale VS experiments. The MDRR must store at least 
the docking results and data on the receptor used. Three ATs can be utilised in this scenario. An AT to calculate 
similarities between the structure of receptors known as structural alignment (AT1), an AT to assess whether the 
structural alignment result shows that the two receptors are similar (AT2), and an AT to assess a docking result and 
categorise it as good (AT3). Finally, a DM is needed to summarise the analysis and suggest which receptor-ligand 
pair to dock next. When compared to the basic diagram of the generic framework on Figure 1, we can state that an 
ADS is not required in this scenario. However, all other components of the framework have been utilised and mapped 
to desired and appropriate functional elements. The flow of data is shown in Figure 6.  
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Figure 6 – Basic diagram of Scenario 1. User conducts docking (1) and results may be sent to the MDRR (2). The 
MDRR sends receptor pairs to AT1 (3) which calculates receptor similarities and sends results to AT2 for assessment 
(4). AT2 sends feedback to the MDRR (5) and the DM (6). Past docking results of similar receptors are assessed by 
AT3 (7) and only good results are sent to the DM (8). The DM combines results from ATs, suggests a receptor-ligand 
pair to dock in the future, and sends it for storage in the MDRR (9), which sends it to the MDE (10) and the user (11). 
 
 
Figure 7 – Extract of the detailed diagram of Scenario 1. Based on the type of input/output interface 1 is broken down 
into 1a-e, while interface 3 into 3a-c. Data from 1a-c is used as input to the subcomponent responsible for VS, 
Raccoon2 gUSE. Data from 1d (AutoDock Vina threshold), and 1e (DeepAlign threshold) is forwarded. 
Based on the detailed diagram of the generic framework and the basic diagram of the scenario, a detailed diagram 
of each scenario can be derived, followed by textual and formal descriptions of these scenarios. At this stage, the 
functional elements of the basic diagram are replaced by either existing already implemented components or by 
custom components that need to be implemented. This process is conducted iteratively, utilising Techniques 2 or 3 of 
the methodology in order to determine whether an already implemented tool can be reused. Technique 2 requires a 
library of abstract descriptions of already implemented elements, which did not exist prior to the design and 
implementation of Scenario 1. Section 5.2 shows how this technique can be used for Scenario 2, while the following 
paragraphs show the use of Technique 3. 
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In Scenario 1, any existing docking tool can be used as MDE, if it fits the description of element type MDE. One 
candidate can be the cloud-enabled version of Raccoon2, described in detail in our previous paper [51]. In this 
solution, WS-PGRADE/gUSE was integrated with Raccoon2 to support large-scale experiments on heterogeneous 
cloud computing resources. To determine whether the extended version of Raccoon2 can be used, following 
Technique 3, a diagrammatic (Figure 7), textual, and formal (Figure 8) description of the tool and its interfaces shall 
be created. The detailed diagram of Raccoon2 in Figure 7 can be derived from the detailed diagram of the generic 
element type MDE (top left in Figure 2). The core computation that is required (conduct docking/VS simulations) is 
achieved by the Raccoon2 solution. It is evident that the defined types of interfaces already exist as part of this solution 
(marked in black in Figure 7), but there is a need to further extend Raccoon2 to include additional interfaces, for 
example to facilitate communication with the MDRR (red in Figure 7).  
The textual description can be derived from the textual description of the generic interfaces shown in Section 3 
and it includes the interfaces presented in Figure 7. Examples of the additional (red) interfaces required include: 
3a-c. Raccoon2 → MDRR, Raccoon2 needs to provide an interface to the docking results which may be sent to the 
MDRR, and the receptor and user-provided thresholds which shall be sent to the MDRR. 
4. MDRR → Raccoon2, Raccoon2 requires an interface to receive suggested ligand for next docking from MDRR. 
 
Figure 8 – Extract of the formal description of Scenario 1. A specific MDE which uses Raccoon2 and the 
function dockingWithConfig() whose main formula reads: for each non-empty ligand l and receptor r received, there 
exists a non-empty config c and docking result res, such that dockingWithConfig(l, r, c) = res. 
 
Similarly, a formal description can be used to deduce whether Raccoon2 can be applied as an element in Scenario 
1. A manual comparison of the formal descriptions which are written using Z notation is needed. If the formal 
description of the candidate tool can be derived from the formal description of the generic element type, then this 
candidate tool can be applied as an element. Otherwise, it cannot. Figure 8 shows that the description of Raccoon2 
using Z notation is derived from the description of the generic element type MDE using Z notation (Figures 3 and 4). 
The definition of dockingWithConfig is used because docking with Raccoon2 always requires a config file. 
Analogously to the Docking and MolecularDockingEnvironment schemas of Figures 3 and 4, the schema 
Docking_AutoDockVina can be included within the schema MolecularDockingEnvironment_Raccoon2.  
Using Technique 3, similarly to the process detailed above in case of the MDE, we have determined that the 
existing structural alignment tool DeepAlign can be used as the element AT1. We have also concluded that there is a 
need to develop custom-made tools to be used as AT2, AT3, DM, and MDDR. Additionally, as specified in the 
methodology, life scientists from the University of Westminster (UoW) took part in the development process, e.g. 
when deciding the molecular properties stored in the MDRR.  
Based on the design considerations illustrated above, we can implement Scenario 1. The diagrammatic, formal, 
and textual abstract description of the elements, as well as the use of the three techniques, show which specific tools 
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can be used in an implementation. The framework and methodology are independent of the programming language 
or database technology applied. In our example, Python, and the micro web-framework Bottle [52] were used to 
implement basic RESTful APIs for every element. The Python module PyBel [53] was used to calculate molecular 
properties of ligands and receptors and they were stored in a MongoDB database as part of the MDRR. One of the 
reasons for choosing MongoDB was its schema-less design which enables using a single collection to store different 
formats of data from the MDE or the ATs. 
Figure 9 shows the architecture of this implementation of Scenario 1. The solid lines represent the communication 
between servers through HTTP, while the dashed lines represent communication between different objects within one 
server (e.g. AT1 --> AT2). In this implementation, the MDRR receives the output from the MDE as a HTTP request 
(1) and stores it. Then, all unique receptors in the database are sent to the AT:DeepAlign along with the target receptor 
that was used in the MDE and the user-input DeepAlign threshold value (2). DeepAlign is run to find similarities 
between the target receptor and each additional receptor it received. The results are sent to AT:AssessDeepAlign (3) 
which selects the similar receptors by comparing the results of DeepAlign to the user-input threshold and returns it to 
the DM (4) which forwards them to the MDRR (7).  
 
Figure 9 – Architecture of implementation of Scenario 1. Grey rectangles signify HTTP servers; white blocks 
signify elements. In this implementation, the MDRR contains a MongoDB database which is deployed on a 
database server, while AT: DeepAlign and AT: AssessDeepAlign are deployed on the same server.  
 
In the next step, the MDRR sends previous docking results that have used a similar receptor to the 
AT:AssessDocking, along with the user-input AutoDock Vina affinity threshold (5). The AT:AssessDocking selects 
a docking result with affinity lower than this threshold, labels it a good docking result, and returns it to the DM (6). 
The DM combines these two lists and returns a list, sorted firstly based on the DeepAlign result value then on the 
affinity, to the MDRR (7) which presents the results to the MDE (8). 
5.2 Design and Implementation of Scenario 2 
The design of Scenario 1 illustrated how Techniques 1 and 3 can be applied. To illustrate how Technique 2 works, 
the design and implementation of Scenario 2 is presented here. In Scenario 2, the user runs a VS experiment, then 
ligands of good docking results are filtered based on a property available in an external ADS. The result is a sub-list 
of ligands that are more likely to produce useful laboratory results.  
A basic diagram of Scenario 2 (Figure 10) can be derived from the basic diagram of the framework, similarly to 
the process explained in Section 5.1. Thus, we can conclude that Scenario 2 fits the framework (Technique 1). To 
provide a more precise analysis, the detailed diagram for each element and their interfaces can be determined. A list 
of the interfaces and a formal description were generated iteratively to confirm that the selected existing elements can 
be used in Scenario 2 prior to starting the coding step. The design of Scenario 2 used both Technique 2 and Technique 
3 but this section only focuses on segments that are different from the design of Scenario 1, and comments on the 
added value of implementing Scenario 2. 
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Figure 10 – Basic diagram of Scenario 2. User conducts docking (1) and results are sent to the MDRR (2). The 
MDRR sends docking results to AT1 which assesses whether the docking is good and returns feedback to the 
MDRR (3) and the DM (4). The DM combines this with data about ligand properties from the ADS (5), sends a 
decision to the MDRR (6) which stores it and sends it to the MDE (7), which visualises it for the user (8). 
 
The MDE from Scenario 1 can be reused with the only difference that instead of a DeepAlign threshold, the user 
now inputs a molecular property name and threshold. When drawing the detailed diagram of the needed MDE, it 
becomes evident that most of the interfaces are the same, and the core computation (the docking) is the same as in the 
detailed diagram of Raccoon2 used for Scenario 1. The conclusion is that the abstract description of Raccoon2 is 
similar enough for it to be used as an MDE in Scenario 2. The fact that the element can be reused is determined by 
searching a library of abstract descriptions of already implemented elements (Technique 2). This library contains only 
one MDE, but the same method of drawing the detailed diagram and comparing the interfaces and the core 
computation, can be used to search a larger library. When writing the formal description of the needed MDE we 
noticed that the Z notation is practically the same as the only Z notation of an MDE currently in the library. Manually 
comparing the formal description of the required element and the element in the library led to the decision that the 
MDE in the library can be reused in Scenario 2.  
Technique 2 can also be used to determine which tool can be applied as AT to assess docking in Scenario 2. There 
is a library of three already implemented ATs from Scenario 1. Their diagrammatic abstract descriptions are shown 
in Figure 11B, C, and D. When the AT required in Scenario 2 (Figure 11A) is compared to AT:DeepAlign (Figure 
11B), there is a clear difference in the interfaces. AT:DeepAlign needs to send the results and a user-provided 
threshold to another AT for assessment. Whereas the required AT assesses docking results and sends them to an 
MDRR for storage, and a DM for summarising. When compared to AT:AssessDeepAlign (Figure 11C), there are 
more similarities in the interfaces. The difference is that AT:AssessDeepAlign requires input from another AT, 
whereas the required AT needs input from an MDRR. However, there is a big difference in the core computation. 
While AT:AssessDeepAlign filters structural alignment results, the required AT needs to filter docking results. 
Finally, when comparing the required AT with AT:AssessDocking (Figure 11D), it is clear that the interfaces are the 
same (requires input from MDRR, provides results to MDRR and DM), and the core computation is the same (assess 
docking results). Therefore, AT:AssessDocking can be reused as a building block of Scenario 2.  
Additionally, Scenario 2 demonstrates how a new element type can be introduced. As it was noted before, in 
Scenario 1 there was no ADS. Following Technique 3, we determined that PubChem [54], a repository that contains 
data about various properties of chemical compounds, can be used as ADS in Scenario 2. Data stored in PubChem 
can be accessed programmatically through the Power User Gateway (PUG) REST API. Thus, this existing interface 
can be used to obtain the needed value for the molecular property of the ligands, and PubChem can be used as an 
ADS. Finally, it can be noted that the DM is an element that is typically specific to each scenario, due to the inherent 
difference in the core computation. 
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Figure 11 – Diagrammatic abstract descriptions of the required AT (A) and the three elements already present 
in the library of abstract descriptions (B, C, D). This diagram is used to determine whether any already implemented 
elements can be reused – note the similarities between interfaces and core computation between A and D.  
 
This section illustrated the use of Techniques 1, 2, and 3. Technique 1 uses the basic diagram, while Techniques 
2 and 3 use the diagrammatic, textual, and formal description of elements. In the design of Scenario 2, we only show 
the use of the diagrammatic description, but the textual and formal descriptions can be used analogously. 
Based on the above design of Scenario 2, the code can be implemented (source code available in [49]). In the 
implementation of Scenario 2, similarly to the implementation of Scenario 1, all components are accessible via a 
RESTful API developed using the Bottle web framework (Figure 12). The docking results are sent from the MDE to 
the MDRR (1), which forwards them to the AT:AssessDocking (2). Filtered good docking results are returned to the 
DM (3) which forwards them to the MDRR (6). Then a ligand identifier, known as SMILES code, is selected for each 
ligand that was part of docking results that passed the filter. The MDRR sends these ligand identifiers to the ADS (4) 
which checks if a user-input ligand property is above or below a threshold and returns the result to the DM (5). Finally, 
the DM summarises the results and sends them to the MDRR (6) which sends them to the MDE for visualisation (7). 
 
  
Figure 12 – Architecture of implementation of Scenario 2. Grey rectangles signify HTTP servers; white blocks 
signify elements. In this implementation, the MDRR contains a MongoDB database which is deployed on a 
database server, the AT is deployed on a separate server, while the ADS is deployed on an existing external server.  
 
One of the aims of implementing Scenario 2 was to show how an element that was created in an implementation 
that has utilised the framework and methodology, can be reused. Evidence for this are the elements MDE, the 
AT:AssessDocking, and to some extent the MDRR, which are reused with nearly no alterations. The minor addition 
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was the change of the user-input threshold values required in the MDE, while the AT:AssessDocking was reused 
without any code changes. Another aim was to illustrate how an additional element such as ADS can be included 
(since an ADS was not present in Scenario 1). It is demonstrated in Scenario 2 that the external database PubChem 
and its interfaces can be applied as ADS. Therefore, the MDRR would need to be slightly altered in order to facilitate 
the communication with PubChem. 
6. Usability of implementations that utilise the framework 
Using the framework and methodology provides benefits for software developers by allowing them to determine 
the specific tools needed and reusing existing elements in an efficient way, as shown in Section 5. This is an alternative 
to acquiring the domain knowledge to make this determination. Nevertheless, evidence was still required to 
demonstrate that the designed and implemented solutions are useful for the end-users, the scientists. In order to prove 
that following such a methodical approach does not produce cumbersome and less usable systems, we have conducted 
several usability tests. This section aims to describe the usability of solutions implemented with the framework, but 
it does not aim to present a quantification of the benefits for the end-user. Completing a scenario using currently 
available tools directly (“without” using the framework) was compared to completing the scenario “with” the 
implementation that was based on the framework. The results for Scenario 1, based on the implementation described 
in Section 5.1, are presented in this paper. The focus of the usability tests was the additional analysis provided as a 
result of the scenarios, and not the results of the docking simulations themselves. The docking experiments used the 
ribokinase of a protozoan parasite Trichomonas vaginalis (TV) as a receptor, an adequate config file, and a set of 10 
ligands. The objective was to run this docking experiment and then suggest a receptor-ligand pair that should be used in 
the next molecular docking, based on receptor similarity and previous docking results. The usability tests demonstrated 
that the experiment can be successfully completed with the implemented solution and that it provides significant 
benefits to the scientists when compared to manual execution. 
As a preparation for the tests, the MDRR needed to be filled with relevant previous docking results. It was 
required that the previous docking results include at least one receptor that is similar to our target receptor and has a 
good docking stored in the MDRR. Therefore, a large number of docking simulations were conducted using the 
extended Raccoon2. The private OpenStack-based cloud at the University of Westminster (UoW Cloud) was used as 
the DCI to run the docking simulations. When choosing which receptors to dock in order to fill the MDRR, several a 
priori similar receptors to the TV ribokinase were chosen. Structures of 7 receptors of same type (ribokinase) from 
different species were downloaded from the wwPDB [55]. To ensure that there is structural alignment, DeepAlign 
was run between the TV ribokinase and each of the 7 ribokinases resulting in a high DeepScore value (between 975.47 
and 1491.79). Further 63 receptors were chosen from the RCSB “Molecule of the Month” series [56]. Therefore, a 
total of 70 receptors were used when prefilling the MDRR, 7 of them (10%) a priori similar to the TV ribokinase, and 
63 (90%) other receptors. Each receptor required its own configuration file which was created within the GUI of 
Raccoon2. Care was taken for the cuboid of the config file to cover a part of the receptor, but further analysis for 
biological relevance was not conducted. Finally, a large number of ligands was needed. A total of 2,376 molecules 
approved as drugs somewhere in the world was obtained from ZINC [57] and made up our set of ligands.  
These input files were used to fill the MDRR with 166,320 (70 × 2,376) docking results. For each receptor, 
between 3 and 6 jobs were run on the UoW Cloud, resulting in 393 jobs with mean execution time of 2h 23min 23s.  
Following these preparations, Scenario 1 was completed first “without” using the implementation of Section 5.1 
but manually feeding results into the appropriate tools. This process was then compared to executing the same scenario 
“with” the implementation.  
One observation is that the usability tests “with” the implementation contain fewer manual steps than the usability 
tests “without” the implementation (“with” required 3, while “without” required 6 manual steps). This is because most 
of the steps are automatised. There is no need to locate files on the file system, or manually read through web pages. 
The decrease of manual steps is a major benefit in terms of usability.  
Another benefit is the decrease of complexity of the manual steps. Generally, the user needs to prepare the 
docking or VS in Raccoon2, enter the required user-provided inputs, and wait for the result of the scenario. When 
completing the scenario “without” the implementation, the user would additionally need to complete steps that may 
be considered complex for a biomedical scientist, such as writing and running a small script that would rename 
docking result files to contain the DeepAlign result value in their name. 
Furthermore, running the scenarios “without” the implementation sometimes requires simple, but repetitive 
manual steps such as uploading the structures of receptors and reading the results of the structural alignment multiple 
times. Although not complex, these repetitive manual steps are very error-prone and time-consuming. Using the 
implementations does not have these problems.  
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7. Conclusion and Future Work 
This paper presented a generic framework and a corresponding methodology to implement complex science-
gateway-based environments for the execution of molecular docking experiments extended with the intelligent 
analysis and utilisation of docking results. The framework incorporates a diagrammatic, textual, and formal 
description enabling a modular design and the replacement and reuse of components. The methodology involves 
multiple stakeholders and requires their collaboration in an agile manner. It provides three techniques that can be used 
to determine the specific elements that can be used in a scenario. Following the framework and methodology, the 
implementations of two scenarios were developed and presented.  
The framework and methodology enable the systematic and efficient reuse of existing elements and therefore 
formalise and potentially speed-up the development process. Additionally, users of the implementations, the 
biomedical scientists, will benefit from implementing these types of scenarios using the framework and methodology 
which produces usable systems providing relevant results. The three techniques that are part of the methodology 
require manual comparison between the diagrams, text, and formal descriptions. As future work, we propose 
investigating whether a software tool can be developed to conduct this comparison automatically. 
Although the framework and methodology have been created for systems that store and analyse docking results, 
a similar approach can be used for other domains. The compatibility and effectiveness of this approach in related 
domains in bioinformatics such as the more computationally demanding molecular dynamics simulations could also 
be investigated.  
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